QA: Opiant Pharmaceuticals INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2022_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 69,158,964
1 IntangibleAssetsNetIncludingGoodwill 11,628
2 PropertyPlantAndEquipmentNet 78,107
3 remainder_Assets 1,179,099
4 LiabilitiesCurrent 6,845,558
5 LiabilitiesNoncurrent 673,347
6 remainder_Liabilities 16,069,085
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,014,344
9 ResearchAndDevelopmentExpense 19,662,601
10 remainder_Expenses 12,917,818
11 remainder_Revenues 40,839,783
12 remainder_NetIncome -12,459,506
13 remainder_ComprehensiveNetIncome -27,918
  yvar yval
0 Assets 70,427,798
1 Liabilities 23,587,990
2 Expenses 44,594,763
3 Revenues 40,839,783
4 StockholdersEquity 46,839,808
5 NetIncome -16,214,486
6 ComprehensiveNetIncome -16,228,445
7 BaseVar 95,968,879
8 EconomicCapitalRatiobeforeLimitedLiability 1.83
9 EconomicCapitalRatio 2.91

Edgar->Model Mapping

Feature Distribution

Change over Time